Genome-Wide Association Study (GWAS) for the Infliximab Responsiveness in Korean Inflammatory Bowel Disease Patients. - Zewon Park; Ko-Woon Choi; Doo Won Seo; Sunae Ryu; Jong Gu Lee; Woo Yong Oh (BCB, 2017)